Research Grade Romilkimab (DHE07704)

Catalog No.

DHE07704

Expression system

Mammalian Cells

Species reactivity

Human

Host species

Humanized

Isotype

[VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer

Clonality

Monoclonal

Target

IL13, NC30, Interleukin-13, IL-13, Binetrakin, B-cell stimulatory factor 1, Pitrakinra, Lymphocyte stimulatory factor 1, IL-4, BSF-1, IL4, Interleukin-4

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P35225 & P05112

Applications

Research Grade Biosimilar

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Alternative Names

Bispecific, SAR156597, huTBTI3_2_1, CAS: 1399584-78-1

Clone ID

Romilkimab

A randomised, double-blind, placebo-controlled, 24-week, phase II, proof-of-concept study of romilkimab (SAR156597) in early diffuse cutaneous systemic sclerosis, PMID: 32963047

An update on targeted therapies in systemic sclerosis based on a systematic review from the last 3 years, PMID: 34074331

Bispecific Antibodies for Autoimmune and Inflammatory Diseases: Clinical Progress to Date, PMID: 31916225

Document Download

Research Grade Romilkimab.pdf